International Cancer Advocacy Network (ICAN)

Latest from International Cancer Advocacy Network (ICAN)

Targeting the 'Typos' for Lung Cancer Harboring Rare Genetic Mutations

November 09, 2022

Article

New treatments may stall lung cancer progression in patients with EGFR exon 20 insertion mutations.

Patient With Lung Cancer ‘Stays One Step Ahead’ of His Rare Mutation

October 20, 2022

Podcast

A man with lung cancer shares how learning about his EGFR exon 20 insertion mutation soon after being diagnosed has allowed him to be aggressive when pursuing a cancer treatment tailored to his rare mutation.

Unmet Needs in the Management of EGFR Exon 20–Positive NSCLC

May 27, 2022

Video

Before closing out their discussion on treatment for EGFR Exon 20–Positive NSCLC, experts discuss prominent unmet needs in this setting.

Enrolling in Clinical Trials for EGFR Exon 20–Positive NSCLC

May 20, 2022

Video

A shared discussion on the importance of enrolling in clinical trials for EGFR exon 20–positive NSCLC and improving access to novel therapy for patients.

Improving Quality of Life While Receiving Treatment for NSCLC

May 20, 2022

Video

A focused conversation on how a patient can maintain and improve quality of life while receiving therapy for non–small cell lung cancer.

Support for Patients Undergoing Treatment for NSCLC

May 13, 2022

Video

Comprehensive discussion on support for patients receiving therapy for NSCLC, ranging from care team members to education materials to support groups.